RARA CRAFT DATABASE for FDA Medical Devices
510(k)K183031

FDA DEVICE FACTS

ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL)

Biomerieux S.A.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 11, 2019PRODUCT CODEJWY

Indications for use

ETEST is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria. The system comprises a predefined antibiotic gradient which is used to determine the Minimum Inhibitory Concentration (MIC, in µg/mL) of different antimicrobial agents against microorganisms tested on agar media after overnight incubation. Same Test Design A predefined exponential gradient of the dried and stabilized antibiotic covers a continuous concentration range across 15 two-fold dilutions of a conventional MIC method. Same Inoculation Isolated colonies from culture Same Incubation 35º±2º C for 16 ‒ 20 hours Same Result MIC Same Differences Antmicrobial Agent Meropenem/Vaborbactam Ceftazidime/Avibactam Antmicrobial Concentration Range 0.004/8 ‒ 64/8 µg/mL 0.016/4 ‒ 256/4 µg/mL

K. Standard/Guidance Document Referenced (if applicable): Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA CLSI M02-A12, Performance Standards for Antimicrobial Disk Susceptibility Test; Approved Standard, January 2015. CLSI M07-A10, Method for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, January 2015. CLSI M100-28th ed., Performance Standards for Antimicrobial Susceptibility Testing; Volume 38, No. 1, January 2018.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 26, 2026